Why the study?
Does cardiorespiratory fitness explain the obesity paradox regarding mortality in patients with systolic heart failure?
Does cardiorespiratory fitness explain the obesity paradox regarding mortality in patients with systolic heart failure?
Answers are grounded in this paper and cite their sources.
Cardiorespiratory fitness modifies the obesity paradox in heart failure, indicating that fitness level rather than BMI alone drives the observed survival benefit.
This article refers to ‘Exercise tolerance can explain the obesity paradox in heart failure: data from the MECKI Score Research Group’, by M.F. Piepoli et al., published in this issue on pages 545–553. Obesity is an epidemic, with an ever-increasing proportion of the population at the upper end of the continuum of underweight, normal weight, overweight, obese, and severely obese. Regardless of the measures used to assess obesity, which include body mass index (BMI), waist circumference, and percentage body fat (BF), individuals with obesity are predisposed to various disease states. Obesity has harmful effects on physiological parameters such as lipid composition, glucose tolerance, and levels of inflammation. It also directly impacts cardiovascular health by increasing blood volume, stroke volume, and cardiac output, all of which lead to ventricular dilation and hypertrophy as well as atrial enlargement.1 Nevertheless, while obesity is a clear risk factor for heart failure (HF), substantial data demonstrate an ‘obesity paradox’ where higher BMI and waist circumference are associated with improved outcomes in both men and women with HF.2-4 While conclusions regarding BMI are blurred by the fact that this measure combines fat mass and muscle mass, the obesity paradox in HF is also demonstrated when adiposity is assessed by BF. Systolic HF patients were previously noted to have a 13% reduction in mortality or urgent transplantation for every 1% increase in BF.5 It remains unclear if BF provides direct benefits or if it primarily stimulates muscle mass development. A small study of patients with HF demonstrated that patients with higher BF generally have higher muscular fitness and muscle strength.6 On the opposite end of this spectrum, the catabolic state of cachexia is characterized by muscle wasting and inflammatory immune activation. Muscle wasting, represented by the established marker of low urinary creatinine, was associated with more severe HF and impaired survival in a study of 120 systolic HF patients.7 Cardiorespiratory fitness (CRF) has also demonstrated prognostic significance in HF. Cardiopulmonary exercise testing results are used to evaluate functional status, guide exercise recommendations, and assess efficacy of therapy in HF.8 Directly measured peak oxygen uptake (peak VO2) is the most frequently analysed parameter. Peak VO2 represents cardiac, circulatory, and respiratory function, as well as muscle oxygen use, and adds value to other clinically relevant parameters of prognosis in HF. Higher peak VO2 has been previously shown to lower blood pressure, improve diabetes control, and decrease the risk of coronary heart disease and incident AF.9 Higher peak VO2 was also associated with a lower risk of new-onset HF in a recent study by Khan et al.10 In patients with known HF, an adjusted peak VO2 of <14 mL/kg/min leads to high short-term mortality and has long been recognized as one of the relative indications for transplantation.10, 11 In this issue, Piepoli and colleagues compare all-cause and cardiovascular mortality in persons with systolic HF when stratified by CRF (predicted peak VO2) and BMI in a sample of 4623 persons from the MECKI Score Research Group.12 Median follow-up was 1113 days, during which 951 deaths occurred; 802 of these deaths were attributed to cardiovascular disease. Of the 4843 participants, 1765 had underweight or normal weight BMI (18.5–24.9 kg/m2), 2087 were overweight (25–29.9 kg/m2), and 771 were obese (30.0–34.9 kg/m2); the group of 220 individuals with severe obesity (≥35 kg/m2) were excluded from analysis. Participants were also divided by predicted peak VO2; 1908 had peak VO2 < 50%, 2363 achieved peak VO2 50–80%, and 352 had peak VO2 > 80%. The authors found that higher BMI and predicted peak VO2 each independently predicted total survival and survival free from cardiovascular death (P < 0.001 for each analysis). However, when BMI class was adjusted for absolute peak VO2, age, gender, and LVEF, higher BMI did not confer a statistically significant survival benefit. In an additional confirmatory analysis, when patients in each BMI group were matched by age, gender, LVEF, and absolute peak VO2 to create 628 matched trios, no significant differences in prognosis were seen for either outcome. These data suggest that CRF alters the relationship between obesity and prognosis in patients with HF, and that individuals with HF who are fat but relatively physically fit are less sick than their less fit counterparts. A similar phenomenon was previously demonstrated in 1675 patients with HF, where those with better CRF (peak VO2 ≥ 14 mL/kg/min) had a good prognosis regardless of weight; an obesity survival paradox persisted in those with poor CRF.13 Higher levels of CRF are associated with a reduction in levels of inflammatory markers such as C-reactive protein and natriuretic peptides, and the protective effect of higher levels of CRF may be partly modulated by a decrease in systemic inflammation.4 Decreased levels of inflammation have also previously been observed in HF patients with higher BMI.14 While mechanisms of cross-talk between these biomarkers and anti-inflammatory adipokines such as adiponectin are poorly understood, they may play a key role in regulation of energy balance in skeletal muscle and adipose tissue.15 While it would be interesting to assess peak VO2 adjusted for BF, rather than total body mass, it is clear that efforts to improve CRF and muscular strength in HF are needed throughout the healthcare system. HF with reduced systolic function was recently approved as a diagnosis for cardiac rehabilitation programmes, and the benefits of exercise training have been noted for HF regardless of systolic function.16 Efforts to improve CRF in HF will be complementary to those efforts to increase CRF and prevent obesity in the general population. Conflicts of interest: none declared.
No takes yet. Share an insight, caveat, or question.
Adrienne L. Clark (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: